These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21173501)

  • 1. Neointimal coverage over coronary stent struts crossing the side branch Ostia.
    Sakata Y
    Circ J; 2011; 75(1):51-2. PubMed ID: 21173501
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment by optical coherence tomography of stent struts across side branch. -Comparison of bare-metal stents and drug-elution stents.-.
    Liu Y; Imanishi T; Kubo T; Tanaka A; Kitabata H; Tanimoto T; Ino Y; Ikejima H; Tsujioka H; Komukai K; Ishibashi K; Kashiwagi M; Ozaki Y; Hirata K; Mizukoshi M; Akasaka T
    Circ J; 2011; 75(1):106-12. PubMed ID: 21041972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of neointimal coverage of sirolimus-eluting stents and paclitaxel-eluting stents using optical coherence tomography at 9 months after implantation.
    Kim JS; Kim JS; Kim TH; Fan C; Lee JM; Kim W; Ko YG; Choi D; Hong MK; Jang Y
    Circ J; 2010 Feb; 74(2):320-6. PubMed ID: 20019414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of neointimal coverage of sirolimus-eluting stents--evaluation with optical coherence tomography.
    Ishigami K; Uemura S; Morikawa Y; Soeda T; Okayama S; Nishida T; Takemoto Y; Onoue K; Somekawa S; Takeda Y; Kawata H; Horii M; Saito Y
    Circ J; 2009 Dec; 73(12):2300-7. PubMed ID: 19789417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed neointimalization on drug-eluting stents--speculation from optical coherence tomography.
    Shite J
    Circ J; 2009 Dec; 73(12):2210-1. PubMed ID: 19940371
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.
    Kim JS; Jang IK; Fan C; Kim TH; Kim JS; Park SM; Choi EY; Lee SH; Ko YG; Choi D; Hong MK; Jang Y
    JACC Cardiovasc Interv; 2009 Dec; 2(12):1240-7. PubMed ID: 20129551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
    Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
    Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography.
    Gomez-Lara J; Brugaletta S; Farooq V; Onuma Y; Diletti R; Windecker S; Thuesen L; McClean D; Koolen J; Whitbourn R; Dudek D; Smits PC; Chevalier B; Regar E; Veldhof S; Rapoza R; Ormiston JA; Garcia-Garcia HM; Serruys PW
    JACC Cardiovasc Interv; 2011 Dec; 4(12):1271-80. PubMed ID: 22192368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of shear stress on neointimal response following sirolimus- and paclitaxel-eluting stent implantation compared with bare-metal stents in humans.
    Papafaklis MI; Bourantas CV; Theodorakis PE; Katsouras CS; Naka KK; Fotiadis DI; Michalis LK
    JACC Cardiovasc Interv; 2010 Nov; 3(11):1181-9. PubMed ID: 21087755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal course of neointimal formation after drug-eluting stent placement: is our understanding of restenosis changing?
    Finn AV; Nakazawa G; Kolodgie FD; Virmani R
    JACC Cardiovasc Interv; 2009 Apr; 2(4):300-2. PubMed ID: 19463440
    [No Abstract]   [Full Text] [Related]  

  • 12. Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents.
    Guagliumi G; Musumeci G; Sirbu V; Bezerra HG; Suzuki N; Fiocca L; Matiashvili A; Lortkipanidze N; Trivisonno A; Valsecchi O; Biondi-Zoccai G; Costa MA;
    JACC Cardiovasc Interv; 2010 May; 3(5):531-9. PubMed ID: 20488410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Very late stent thrombosis after drug-eluting stent in segment with neointimal tissue coverage.
    Nishiguchi T; Kitabata H; Tanaka A; Kataiwa H; Ishibashi K; Komukai K; Tanimoto T; Ino Y; Takarada S; Kubo T; Nakamura N; Mizukoshi M; Imanishi T; Akasaka T
    JACC Cardiovasc Imaging; 2010 Apr; 3(4):445-6. PubMed ID: 20394907
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term vascular healing in response to sirolimus- and paclitaxel-eluting stents: an optical coherence tomography study.
    Räber L; Baumgartner S; Garcia-Garcia HM; Kalesan B; Justiz J; Pilgrim T; Moschovitis A; Khattab AA; Buellesfeld L; Wenaweser P; Meier B; Serruys PW; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2012 Sep; 5(9):946-57. PubMed ID: 22995882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis.
    Nakazawa G; Vorpahl M; Finn AV; Narula J; Virmani R
    JACC Cardiovasc Imaging; 2009 May; 2(5):625-8. PubMed ID: 19442951
    [No Abstract]   [Full Text] [Related]  

  • 16. Advanced neointimal growth is not associated with a low risk of in-stent thrombus. Optical coherence tomographic findings after first-generation drug-eluting stent implantation.
    Murakami D; Takano M; Yamamoto M; Inami S; Ohba T; Seino Y; Mizuno K
    Circ J; 2009 Sep; 73(9):1627-34. PubMed ID: 19667489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatial distribution of neo-intimal hyperplasia 6 months after zotarolimus-eluting stent implantation, analysed by optical coherence tomography.
    Souteyrand G; Levesque S; Ouchchane L; Sarry L; Eschalier R; Lusson JR; Motreff P
    Arch Cardiovasc Dis; 2011 Mar; 104(3):147-54. PubMed ID: 21497303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal stent expansion and complete neointimal coverage: does this association make sense?
    Mintz GS; Choi SY
    JACC Cardiovasc Interv; 2009 Oct; 2(10):995-6. PubMed ID: 19850261
    [No Abstract]   [Full Text] [Related]  

  • 19. Strut coverage and vessel wall response to zotarolimus-eluting and bare-metal stents implanted in patients with ST-segment elevation myocardial infarction: the OCTAMI (Optical Coherence Tomography in Acute Myocardial Infarction) Study.
    Guagliumi G; Sirbu V; Bezerra H; Biondi-Zoccai G; Fiocca L; Musumeci G; Matiashvili A; Lortkipanidze N; Tahara S; Valsecchi O; Costa M
    JACC Cardiovasc Interv; 2010 Jun; 3(6):680-7. PubMed ID: 20630463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherosclerotic and thrombogenic neointima formed over sirolimus drug-eluting stent: an angioscopic study.
    Higo T; Ueda Y; Oyabu J; Okada K; Nishio M; Hirata A; Kashiwase K; Ogasawara N; Hirotani S; Kodama K
    JACC Cardiovasc Imaging; 2009 May; 2(5):616-24. PubMed ID: 19442950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.